• Return to Headlines

Atrion Corp Shares Up 29.6% Since SmarTrend's Buy Recommendation (ATRI)

By Nick Russo

SmarTrend identified an Uptrend for Atrion Corp (NASDAQ:ATRI) on April 19th, 2017 at $487.00. In approximately 3 months, Atrion Corp has returned 29.58% as of today's recent price of $631.05.

Atrion Corp share prices have moved between a 52-week high of $691.95 and a 52-week low of $393.95 and are now trading 60% above that low price at $631.05 per share. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.4%.

Atrion Corporation, through its subsidiaries, designs, develops, manufactures, markets, sells, and distributes medical products and components. The Company's products are used in ophthalmic, diagnostic, and cardiovascular procedures. Atrion's products are sold primarily to health care companies which market and distribute its products in conjunction with their name-brand products.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Atrion Corp shares.

Log in and add Atrion Corp (ATRI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights atrion corp

Ticker(s): ATRI